# Clinical Trials & Research

> Latest research studies and clinical trial results involving peptides and related therapeutics.

6 articles.

- [Tesamorelin and Cognitive Health in Aging](https://moleculenotes.com/cognitive-health-and-aging/tesamorelin-cognitive-function-aging-research.md): Discover how tesamorelin cognitive function aging research reveals brain health benefits. Learn the science behind this breakthrough. Read now.
- [Selank Semax Stack: Cognitive Nootropic Peptides](https://moleculenotes.com/cognitive-health-and-aging/selank-and-semax-stack-cognitive-nootropic-peptides.md): Learn how the Selank and Semax stack cognitive nootropic peptides enhances mental performance. Discover synergistic benefits for focus and clarity today.
- [Why BPC-157 Isn't FDA Approved Yet](https://moleculenotes.com/regulatory-and-approval-status/why-is-bpc-157-not-approved-by-fda.md): Why is BPC-157 not approved by FDA despite 150 studies. Discover regulatory, funding, and trial barriers that have stalled this compound for decades.
- [Retatrutide HbA1c Reduction Diabetes Study](https://moleculenotes.com/clinical-trials-and-research/retatrutide-hba1c-reduction-diabetes-study.md): Explore how retatrutide's impressive HbA1c reduction and weight loss potential can help manage type 2 diabetes effectively. Read the latest study insights now.
- [TRIUMPH Trial Retatrutide Phase 3 Obesity Study](https://moleculenotes.com/clinical-trials-and-research/triumph-trial-retatrutide-phase-3-obesity.md): Discover the triumph trial for retatrutide phase 3 and its impact on obesity treatment. Learn how this study could influence FDA approval. Read more today.
- [Retatrutide NEJM 2023 Phase 2 Obesity Results](https://moleculenotes.com/clinical-trials-and-research/retatrutide-nejm-2023-phase-2-obesity.md): Explore the retatrutide NEJM 2023 phase 2 obesity trial results showing 24.2% weight loss. Read more to understand its potential in obesity treatment.